As of May 22
| +0.59 / +0.88%|
The 10 analysts offering 12-month price forecasts for Isis Pharmaceuticals Inc have a median target of 67.50, with a high estimate of 95.00 and a low estimate of 11.00. The median estimate represents a -0.38% decrease from the last price of 67.76.
The current consensus among 12 polled investment analysts is to Hold stock in Isis Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.